A large number of C-4 paclitaxel analogs have been prepared in the cou
rse of our systematic C-4 modification. These include C-4 esters, carb
onates, carbamates as well as a C-4 deacetyl derivative. All of these
analogs were evaluated in a tubulin polymerization assay as well as in
a cytotoxicity assay against a human colon cancer cell line. The pote
nt analogs emerging from these in vitro assays were further evaluated
in vivo. With the exception of paclitaxel side chain bearing C-4 carba
mates and C-4 aromatic esters, most of the C-4 aliphatic esters and ca
rbonates were found to possess comparable or superior activity to pacl
itaxel in vitro. Several C-4 aliphatic esters and carbonates also exhi
bited in vivo activities against i.p. implanted murine M-109 lung carc
inoma.